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Laminin-5 is the major adhesion ligand of epithelial
cells. Mutations in the three genes (LAMA3, LAMB3,
LAMC2) encoding the laminin-5 chains cause junc-
tional epidermolysis bullosa, a clinically and genetic-
ally heterogeneous blistering skin disease. Here, we
describe a non-Herlitz junctional epidermolysis bul-
losa patient, compound heterozygote for two novel
mutations affecting the LAMC2 gene. The mutation
in the paternal allele is a de novo splice site mutation
(522-1G®A) that results in in-frame skipping of
exon 4 and synthesis of a mutated g2 polypeptide
(g2D4) carrying a 33 amino acid deletion within the
N-terminal domain V. The maternal mutation is a
one base pair insertion (3511insA) in the 3¢ terminal
exon of LAMC2 resulting in a frameshift and a pre-
mature termination codon. Mutation 3511insA is
predicted to lead to the synthesis of a g2 polypeptide
(g2t) disrupted in its a-helical C-terminal structure
and truncated of the last 25 amino acids.
Keratinocytes isolated from the patient's skin showed
a markedly decreased level of g2 chain mRNA and
secreted scant amounts of laminin-5, which under-
goes physiologic proteolytic processing. To investi-
gate the biologic function of the laminin-5 molecules
synthesized by the patient, mutant g2 cDNAs were
transiently expressed in g2-null keratinocytes.
Transfection of the g2D4 cDNA resulted in restor-
ation of laminin-5 deposition onto the culture sub-
strate, which demonstrates that the g2 polypeptides
carrying a deletion in domain V, upstream of the g2
proteolytic cleavage site, are assembled into native
laminin-5 that is secreted and extracellularly pro-
cessed. In contrast, transfection of a mutant cDNA
expressing the g2t chain failed to restore laminin-5
immunoreactivity, which indicates that integrity of
the g2 C-terminal amino acid sequences is required
for laminin-5 assembly. These results correlate for
the ®rst time a functional alteration in a laminin-5
domain with a mild junctional epidermolysis bullosa
phenotype. Key words: inherited blistering skin diseases/
laminin g2 chain/molecular genetics. J Invest Dermatol
117:731±739, 2001
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aminin-5 is a laminin isoform that constitutes the major
adhesion ligand of epithelial cells and a putative
component of the anchoring ®laments, thread-like
structures that span the lamina lucida in the basement
membrane of the skin and mucous epithelia (Rousselle
et al, 1991). Laminin-5 is synthesized within the basal epithelial cells
as a heterotrimeric molecule composed of an a3 (200 kDa), a b3
(140 kDa) and a g2 (155 kDa) chain that associate in their
C-terminal domains to form a triple-stranded a-helical coiled-coil
rod domain (Engel et al, 1991). After assembly, laminin-5 molecules
are secreted in the extracellular matrix where laminin-5 is found in
two forms of 440 and 400 kDa. The 440 kDa trimer is generated
by proteolytic cleavage of the a3 chain (Marinkovich et al, 1992).
Extracellular processing also removes domains IV and V of the
laminin g2 short arm, shortening the g2 polypeptide from 155 kDa
to 105 kDa and reducing the size of laminin-5 to 400 kDa. The
role of bone morphogenetic protein 1 in cleaving the g2 chains in
normal human keratinocytes as well as the localization of the
cleavage site within the g2 chain short arm have been recently
described (Amano et al, 2000).
Laminin-5 has been shown to bind to cells via two integrin
receptors, a3b1 and a6b4 (for review see Borradori and
Sonnenberg, 1999). The a6b4 integrin is a transmembrane
component of hemidesmosomes, the dense cytoplasmic devices
that connect the basal cells of strati®ed and pseudostrati®ed epithelia
to the lamina densa through anchoring ®laments. The essential role
of laminin-5 and a6b4 integrin in epidermal±dermal adhesion has
been con®rmed by the ®nding that mutations in either molecule
cause junctional epidermolysis bullosa (JEB). JEB is a clinically and
genetically heterogeneous group of inherited blistering disorders of
skin and mucous membranes, characterized by mesenchymal±
epithelial separation within the lamina lucida of the basement
membrane zone and by hemidesmosomal abnormalities. On the
basis of the clinical severity JEB patients with laminin-5 mutations
have been classi®ed into the Herlitz (lethal) and non-Herlitz
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(nonlethal) types (Fine et al, 2000). The Herlitz variant of JEB (H
JEB) is usually associated with mutations resulting in premature
termination codons (PTC) in the genes (LAMA3, LAMB3,
LAMC2) encoding the three laminin-5 chains. As a result of
these PTC mutations, the synthesis of one laminin-5 chain is
completely abolished and no functional trimeric laminin-5 is
formed, explaining the morphologic abnormalities in hemidesmo-
some±anchoring ®lament complexes and the severe defect in
epithelial cell adhesion (Aberdam et al, 1994; Pulkkinen et al,
1994a; Kivirikko et al, 1995). On the other hand, several patients
are affected with the non-Herlitz form of JEB (non-H JEB), which
is associated with missense or exon-skipping mutations in at least
one allele of the LAMB3 and LAMC2 genes (Pulkkinen et al,
1994b, 1998; McGrath et al, 1996, 1999; Posteraro et al, 1998). The
homozygous or heterozygous inheritance of these mutations in the
same gene leads to a reduced expression of laminin-5 molecules,
which maintain a residual biologic activity (Posteraro et al, 1998;
Pulkkinen et al, 1998; McGrath et al, 1999).
In this study we have identi®ed the molecular defect in a child
affected with non-H JEB who is a compound heterozygote for two
novel LAMC2 mutations leading to reduced g2 chain mRNA
levels and laminin-5 secretion. Through the expression of the
mutant proteins in a g2-null keratinocyte cell line, we have also
assessed the consequences of each mutation on laminin-5 assembly,
secretion, and deposition.
MATERIALS AND METHODS
Case report The proband, a 7-y-old male, was the ®rst child of
healthy, nonconsanguineous parents. The patient had a history of
generalized trauma-induced skin blisters and erosions since birth.
Mucosal lesions were limited to transient blisters of the nasal cavity. Nail
and tooth dystrophies were also present, but hair was not affected and
growth was within normal limits. The diagnosis of JEB was con®rmed
by ultrastructural examination of a skin biopsy that showed the plane of
cleavage to lie within the lamina lucida of the dermal±epidermal junction
(DEJ) and the presence of hypoplastic hemidesmosomes (not shown).
Cell cultures Human epidermal keratinocytes were obtained from skin
biopsies of the proband and healthy controls and cultivated on a feeder
layer of lethally irradiated 3T3-J2 murine ®broblasts (a gift from H.
Green, Harvard Medical School, Boston, MA), as described previously
(Zambruno et al, 1995). For transfection experiments, SV40-
immortalized H JEB keratinocytes (LSV5 cell line) that do not express
laminin-5 as a consequence of a homozygous nonsense mutation (R95X)
in the LAMC2 gene were used (Miquel et al, 1996).
Immuno¯uorescence studies Frozen sections 5 mm thick were
obtained from skin biopsies of the proband and healthy controls and
processed for immuno¯uorescence using a three-step biotin±streptavidin±
¯uorescein procedure, as described previously (Kanitakis et al, 1989).
Cultured primary and transfected keratinocytes, grown on glass coverslips
in six-well tissue culture plates, were subjected to an indirect
immuno¯uorescence procedure (Gagnoux-Palacios et al, 1996). The
following monoclonal antibodies (MoAb) and polyclonal antisera (pAb)
were used: GB3 (mouse MoAb to laminin-5) (Verrando et al, 1991),
K140 (mouse MoAb to the laminin-5 b3 chain; gift from R. Burgeson,
Cutaneous Biology Research Center, Charlestown, MA) (Marinkovich et
al, 1992), BM-165 (MoAb to the laminin-5 a3 chain; gift from R.
Burgeson) (Rousselle et al, 1991), SE85 (rabbit pAb to the laminin-5 a3
chain) (Baudoin et al, 1994a), SE144 (rabbit pAb to the laminin-5 g2
chain) (Vailly et al, 1994), 1A8C (mouse MoAb to BPAG2 antigen; gift
from K. Owaribe, Nagoya University, Nagoya, Japan) (Owaribe et al,
1991), G0H3 (rat MoAb to the a6 integrin subunit; gift from A.
Sonnenberg, Netherland Cancer Institute, Amsterdam, The Netherlands)
(Sonnenberg et al, 1987), and 3E1 (mouse MoAb to the b4 integrin
subunit; Telios Pharmaceuticals, San Diego, CA).
Immunoprecipitation analysis Subcon¯uent keratinocytes were
incubated overnight in methionine-cysteine-free medium, in the
presence of 100 mCi per ml of [35S] methionine and cysteine (Amersham
Pharmacia Biotech, Little Chalfont, U.K.). Cells were detached with
10 mM ethylenediamine tetraacetic acid in phosphate-buffered saline
(PBS) pH 7.4 and washed in PBS containing 1 mM CaCl2 and 1 mM
MgCl2. Cells were then lyzed in RIPA buffer (50 mM Tris-HCl,
150 nM NaCl, 1% deoxycolate, 1% Triton X-100, 0.1% sodium dodecyl
sulfate, 0.2% sodium azide) pH 7.5 containing protease inhibitors
(Complete, Roche Molecular Biochemicals, Mannheim, Germany).
Immunoprecipitations of culture medium and cell lysates were carried
out by overnight incubation at 4°C of the immunoadsorbents (antibodies
adsorbed onto Protein A-Sepharose, Amersham Pharmacia Biotech) with
samples of culture medium and cell lysates, followed by extensive
washing and elution by boiling in Laemmli sample buffer. Samples were
then separated on 6% polyacrylamide gels under reducing conditions,
followed by autoradiography. Quantitation of autoradiograms was
performed by densitometric scanning with a Gel Doc 1000 (Bio-Rad,
Hercules, CA).
Northern analysis Total RNA from primary cultures of epidermal
keratinocytes was prepared by the guanidinium-thiocyanate method, as
described previously (Chomczynsky and Sacchi, 1987). For each sample,
20 mg of total RNA were separated by electrophoresis through a 1.0%
agarose/formaldehyde gel and transferred to Hybond N nylon membrane
in 20 3 sodium citrate/chloride buffer, as described by the supplier
(Amersham Pharmacia Biotech). Membranes were hybridized at high
stringency with 32P-labeled probes NA1 (Baudoin et al, 1994a), Kal-5.5
(Gerecke et al, 1994), and PCR 1.3 (Vailly et al, 1994) to detect the
mRNA for laminin-5 a3, b3, and g2 chains, respectively. For loading
control, membranes were hybridized with a probe corresponding to the
ubiquitously expressed glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) gene. Quantitation of autoradiograms was performed as
described above.
Mutation detection and veri®cation Genomic DNA was extracted
from peripheral blood of the proband, the parents, and the controls by
standard methods. 100 ng of total DNA were used as a template for
ampli®cation of individual exons of LAMC2 gene, as described
previously (Pulkkinen et al, 1997). Speci®cally, to amplify a 205 bp
region of the LAMC2 gene comprising exon 4, primers were (L) 5¢
GTTGTGAAGCATTTGGAAGC 3¢ and (R) 5¢ CTAGTTGGGCAA-
GGGACTCT 3¢. Primers used for ampli®cation of a 462 bp portion of
the LAMC2 gene containing exon 23 were (L) 5¢ AGTTATGGG-
TATAGAAGGGC 3¢ and (R) 5¢ TGACCTGAGCATACCCATTA 3¢.
Polymerase chain reaction (PCR) ampli®cation products were subjected
to heteroduplex analysis, according to the manufacturer's instructions
(MDE, FMC Corporation, Rockland, ME). If a heteroduplex band was
detected, the PCR product was subcloned and sequenced, as described
by Posteraro et al (1998). Allele-speci®c oligonucleotide (ASO) analysis
was carried out to verify mutations and to assess their inheritance in the
kindred, as described previously (Ruzzi et al, 1997). For the exon 23
mutation the ASO used were 5¢ CGAGCCAAGACCCAGATCAA 3¢
for the wild-type allele and 5¢ CGAGCCAAGAACCCAGATCA 3¢ for
the mutated allele. To verify the exon 4 mutation the ASO were 5¢
TCTTCTTCCCCAGAGACT 3¢ for the wild-type allele and 5¢
CTTCTTCCCCAAAGACTC 3¢ for the mutated allele. Nucleotide
positions for mutations and polymorphism described in this study are
according to LAMC2 cDNA (Kallunki et al, 1992; GenBank accession #
Z15008 and Z15009).
Genotype analysis The patient and the parents were genotyped using
the following informative genetic markers: HLA DQa (Spinella et al,
1997), D7S460 (Hudson et al, 1992), ACTBP2 (Polymeropoulos et al,
1992), D1S80 (Wirth et al, 1993), and HUMTH01 (Edwards et al, 1991).
For HLA DQa genotyping we used the HLA DQa forensic DNA
ampli®cation kit (Perkin Elmer, Roche Molecular Systems, Branchburg,
NJ), according to the manufacturer's instructions. An intragenic LAMC2
polymorphism, 858 C/A in exon 6, discovered in the course of this study
was also used for genotype analysis. This polymorphism results in the
amino acid substitution D247E and is detected by AspI restriction
endonuclease digestion (Roche Molecular Biochemicals) of a 222 bp
ampli®cation product containing exon 6 (Pulkkinen et al, 1997). The
allelic frequency, tested on unrelated healthy individuals (60 chromo-
somes), was 86% for C and 14% for A, resulting in a value of 0.212 for the
polymorphism information content.
Reverse transcriptase PCR (RT-PCR) analysis and cDNA
sequencing cDNA was obtained by reverse transcription of total
RNA from the patient's cultured keratinocytes, as described by Posteraro
et al (1998). RT-PCR was carried out using antisense primers that end at
the C/A polymorphism detected at nucleotide position 858 and also
allow us to distinguish between cDNA molecules derived from the two
alleles. For ampli®cation of the paternal transcripts, the primers employed
were (L) 5¢ GCACCCAAGACCAGAGACTG 3¢ (nt 500±519) and (R)
5¢ GGAGCCACAAAATAGACAGGT 3¢ (nt 858±878). For ampli®c-
ation of maternal transcripts the sense primer was the same as above and
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the antisense was 5¢ GAGCCACAAAATAGACAGGG 3¢ (nt 858±877).
PCR conditions were: 94°C for 5 min followed by 94°C for 30 s, 65°C
for 30 s, 72°C for 30 s (35 cycles), and extension at 72°C for 10 min.
The PCR products were subjected to direct sequencing by Thermo
Sequenase 33P-radiolabeled terminator cycle method (Amersham
Pharmacia Biotech).
To estimate the relative contribution of the two mutant alleles to the
reduced level of g2 chain mRNA detected by northern analysis, RT-
PCR ampli®cation combined with AspI (Roche Molecular
Biochemicals) restriction enzyme digestion was performed using the
following primers: (L) 5¢ GCAGCTCTGCAGAATACAGT 3¢ (nt 707±
726) and (R) 5¢ AGATTCCGCAGTAACCTTCG 3¢ (nt 1126±1145).
The digested PCR products were fractioned by 2% agarose gel
electrophoresis.
Plasmids and transient transfection assays Plasmids used in transient
transfection assays to express mutated g2 chains were derived from
plasmid pCg2, which contains the full-length wild-type cDNA encoding
the laminin g2 chain inserted in the expression vector pcDNA3 as
previously described (Gagnoux-Palacios et al, 1996). This plasmid was
used to monitor transfection ef®ciency. Plasmid pCg2D4 was constructed
by replacing the AocI/SrfI (Roche Molecular Biochemicals; Stratagene,
La Jolla, CA) fragment of pCg2 with the corresponding fragment
carrying the in-frame skipping of exon 4, obtained by RT-PCR of total
RNA from the patient's keratinocytes. To generate the pCg2t plasmid
the Eco47III/XhoI (Roche Molecular Biochemicals) fragment of pCg2
was replaced with the corresponding region carrying mutation 3511insA,
obtained by RT-PCR of the patient's keratinocyte total RNA. All the
expression plasmids were characterized by restriction mapping and
sequencing to ensure their identity around cloning sites.
Fifty percent con¯uent LSV5 monolayers grown in six-well tissue
culture plates were transfected using DOSPER liposomal transfection
reagent (Roche Molecular Biochemicals), according to the manufactur-
er's instructions, and subjected to immuno¯uorescence analysis 48 h
later.
RESULTS
Non-H JEB patient's keratinocytes synthesize and secrete a
reduced amount of laminin-5 that undergoes processing and
deposition into the matrix MoAb GB3, which recognizes a
conformational epitope of laminin-5, gave a linear labeling of the
DEJ of markedly reduced intensity in the proband's skin compared
to the staining of normal control skin. Using antibodies directed
against each laminin-5 chain, expression of the laminin g2 and b3
polypeptides appeared greatly reduced whereas staining for the a3
chain was attenuated (not shown). In contrast, immunoreactivity of
the antibodies directed against the other major DEJ components,
including a6b4 integrin and BP180, was similar to healthy
controls.
Immuno¯uorescence analysis of patient's cultured keratinocytes
revealed laminin-5 staining localized both within the keratinocyte
cytoplasm and in the matrix deposited onto the culture vessel.
Labeling intensity, however, appeared markedly reduced compared
to control keratinocytes (Fig 1).
Immunoprecipitation of cultured keratinocyte lysates evidenced
that the precursor a3 (200 kDa) and g2 (155 kDa) laminin-5 chains
as well as the b3 (140 kDa) chain are synthesized in the patient's
keratinocytes, although in reduced amount compared to normal
control keratinocytes (not shown). In addition, immunoprecipita-
tion analysis of spent culture medium of patient's keratinocytes
showed the presence of mature laminin-5 as demonstrated by
detection of a 165 kDa band (a3 chain) and a 105 kDa band (g2
chain) (Fig 2B). The immunoprecipitated bands were much fainter
than in normal keratinocytes, however, and their intensity was
estimated to be about 8% of the normal control by densitometric
analysis. Taken together, immuno¯uorescence and immunopre-
cipitation results show that residual laminin-5 synthesis, secretion,
processing, and deposition into the matrix occur in our non-H JEB
patient.
Northern analysis shows markedly reduced levels of g2
laminin chain mRNA in the non-H JEB patient Northern
analysis with a cDNA probe for the laminin-5 g2 chain resulted in a
signal markedly reduced (by about 70%) in the patient compared
with a control, after correction of the signal by GAPDH mRNA
levels (Fig 2A). In contrast, the signal intensity obtained with
probes for the laminin-5 a3 and b3 subunits was comparable to
controls (not shown). These ®ndings indicate that LAMC2 was the
candidate gene in the disease.
Mutation analysis reveals compound heterozygosity for a
single base insertion and a de novo splice site mutation in
LAMC2 Heteroduplex analysis of the PCR products spanning
the LAMC2 gene in the proband's genomic DNA showed two
distinct shifts, corresponding to exons 4 and 23. Subcloning and
sequencing of the PCR product corresponding to exon 23 detected
the insertion of a single base (A) at nucleotide position 3511,
leading to a frameshift and resulting in a PTC 110 bp downstream
(Fig 3A). Mutation 3511insA predicts a truncated g2 polypeptide
(g2t) terminating at residue 1168 and therefore lacking the
C-terminal 25 amino acids. ASO analysis con®rmed the
heterozygous state of mutation 3511insA in the proband and
demonstrated the maternal inheritance in the kindred (Fig 3B).
Figure 1. Immuno¯uorescence localization
of laminin-5 in non-H JEB keratinocytes.
With antibodies to laminin g2 chain (a, b) and
heterotrimeric laminin-5 (c, d), cytoplasmic
staining as well as labeling of the extracellular
matrix are visible in patient's keratinocytes (a, c).
The intensity of the extracellular staining is
strikingly reduced, however, compared to normal
control (b, d). Bars: 7 mm (a, b); 10 mm (c, d).
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Sequence analysis of the PCR product corresponding to exon 4
and the ¯anking intronic regions detected a G®A substitution at
position ±1 of the 3¢ splice site of intron 3 (Airenne et al, 1996).
This mutation was designated 522-1G®A (Fig 3C). ASO analysis
con®rmed the heterozygous state of the mutation in the proband
(Fig 3D). On the other hand, the PCR products from family
members, including the father, hybridized only with the wild-type
ASO (Fig 3D), suggesting that mutation 522-1G®A occured de
novo in the paternal allele. Paternity was therefore con®rmed by
comparison of ®ve informative polymorphic markers (HLA DQa,
D7S460, ACTBP2, D1S80, HUMTH01) and the intragenic 858
Figure 2. Northern blot and immunoprecipitation analysis of
laminin-5. (A) Expression of LAMC2 gene was assessed by northern
blot of total RNA puri®ed from cultured patient and normal
keratinocytes. Membranes were hybridized with a 32P-labeled LAMC2
speci®c probe and, for loading control, the GAPDH probe. The
intensity of the signal for the g2 chain mRNA appears markedly reduced
in patient (Pt) compared to control keratinocytes (C). (B) Cultured
keratinocytes from the non-H JEB patient (lanes 1, 3) and a healthy
volunteer (lanes 2, 4) were labeled with [35S] methionine and cysteine,
and conditioned media were immunoprecipitated with antibodies against
laminin-5 b3 (lanes 3, 4) and g2 chains (lanes 1, 2). The eluates were
then analyzed on 6% SDS-PAGE gels under reducing conditions.
Protein-bound radioactivity in conditioned media was counted, and
equivalent amounts of radioactivity were immunoprecipitated from
patient and control media. Highly reduced levels of unprocessed and
processed g2 chain are observed in patient's cells (1, 3) in comparison
with normal control keratinocytes (2, 4).
Figure 3. Identi®cation and veri®cation of the heterozygous
mutations 3511insA and 522-1G®A in the proband LAMC2 gene.
(A) Total genomic DNA was subjected to PCR using primers that
amplify a 462 bp region comprising exon 23 of LAMC2 gene. In
comparison with normal control DNA, nucleotide sequencing of
patient's DNA reveals a single base insertion (A at position 3511),
resulting in a frameshift and a PTC 110 bp downstream. The mutation is
designated 3511insA. (B) Veri®cation of mutation 3511insA was
performed by ASO hybridization of PCR products from the parents, the
proband, and a normal control (C). The wild-type (WT) oligomer
hybridizes to all DNA samples, whereas the mutant (M) oligonucleotide
hybridizes only to DNA from the proband and his mother, indicating
that they are heterozygous for mutation 3511insA. (C) Total genomic
DNA was subjected to PCR using primers that amplify a 205 bp region
encompassing LAMC2 exon 4. Compared with the DNA of a normal
control, nucleotide sequencing of non-H JEB patient's DNA reveals a
G-to-A transition at the 3¢ acceptor splice site of intron 3. The mutation
is designated 522-1G®A. (D) ASO analysis performed on 205 bp
amplimers corresponding to exon 4 with wild-type (WT) and mutated
(M) oligomers con®rms the heterozygous state of mutation 522-1G®A
only in the proband's DNA (3), suggesting the de novo occurrence of the
mutation in the paternal allele.
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C/A polymorphism identi®ed in LAMC2 in the course of this
study. This polymorphism is detected by AspI restriction enzyme
digestion. AspI digestion of the PCR product spanning exon 6
(222 bp) revealed that the patient and his father were heterozygous
for the C/A polymorphism, whereas the mother was homozygous
for the C. These results con®rmed that, in the patient, mutation
522-1G®A is brought by the paternal allele. As the mutation is not
found in the father's somatic cells, it most probably originated in
the father's germ-line cells.
The de novo splice site mutation 522-1G®A results in a
major mRNA transcript carrying the in-frame skipping of
exon 4 As mutation 522-1G®A abolishes the canonical 3¢ splice
site consensus sequence, an aberrant splicing was expected. mRNA
from cultured keratinocytes was therefore analyzed by RT-PCR
using antisense oligonucleotides that prime ampli®cation starting
from nucleotide position 858 and thus also allow us to differentiate
transcripts derived from the two alleles. Analysis on 2% agarose gel
of PCR products from the paternal allele (Fig 4A) demonstrated a
279 bp band that results from the in-frame skipping of the exon 4
(99 bp), as con®rmed by nucleotide sequencing of the band isolated
from the gel (Fig 4B, C). This transcript encodes for a mutated g2
polypeptide (g2D4) carrying a 33 amino acid deletion within the
N-terminal g2 domain V. In addition, a faint band corresponding in
size to a normal splicing product was detected. Isolation and direct
sequencing of this minor PCR product identi®ed an abnormal
RNA transcript originating from the activation of a cryptic splice
site that uses the ®rst two nucleotides (AG) of exon 4 as a new
acceptor site (Fig 4B, C). The resulting mRNA transcript carries
an out-of-frame deletion of 2 bp and contains a PTC at nucleotide
position 534. No mRNA transcripts corresponding to a normal
splicing product were identi®ed. Using the primer that anneals to
mRNA molecules derived from the maternal allele, only a 378 bp
fragment corresponding to a normal splicing product was observed
(Fig 4B). The latter ®nding further con®rms that mutation 522-
1G®A arose de novo on the paternal allele.
Both mutant alleles give rise to unstable transcripts that
contribute to the reduced steady-state level of LAMC2
mRNA We then investigated the relative contribution of the
two alleles to the reduced steady-state level of the g2 chain mRNA
detected by northern analysis. RT-PCR of the cDNA region
containing the 858 C/A polymorphism (nt 707±1145), followed by
AspI digestion, showed that the 286 and 153 bp bands that
represent the cleavage products of the maternal cDNA have an
intensity similar to the undigested 439 bp band identifying the
paternal cDNA fragment (Fig 4D). This result indicates that both
mutations affect to a similar degree the decay of the g2 chain
mRNA.
Expression of the mutated g2 chains in g2-null keratinocytes:
the g2D4 polypeptide rescues laminin-5 secretion and matrix
deposition The ability of the two major mutant transcripts to
sustain synthesis and secretion of laminin-5 was then investigated by
transfecting cDNAs encoding mutant g2 polypeptides into the cell
line LSV5. This keratinocyte cell line is derived from an H JEB
patient with a homozygous nonsense mutation (R95X) in the
LAMC2 gene (Miquel et al, 1996). LSV5 cells do not synthesize the
laminin g2 chain, but express the laminin a3 and b3 chains; hence
transfection of a plasmid (pCg2) expressing a wild-type g2 cDNA
restores production of functional laminin-5 molecules (Gagnoux-
Palacios et al, 1996). To assess the biologic activity of the mutated
Figure 4. Allele-speci®c analysis of the transcripts and cDNA
sequencing. (A) RT-PCR ampli®cation of total RNA obtained from
patient's cultured keratinocytes using paternal (lane 1) or maternal (lane 2)
speci®c antisense oligonucleotides that end at the C/A polymorphism
detected at nt 858. Paternal-speci®c PCR products are represented by
two fragments, of 376 and 279 bp. By contrast, a single band of 378 bp
is derived from the maternal allele. (B) Sequencing of 279 bp fragment
shown in lane 1A reveals an aberrant mRNA bearing the in-frame
skipping of exon 4 (99 bp) (mutant cDNA 1), whereas sequencing of the
376 bp band derived from the paternal allele shows an out-of-frame
transcript carrying the deletion of the ®rst two bases of exon 4 (mutant
cDNA 2). (C) In the middle is schematically represented the genomic
structure of the region from exon 3 to exon 5 of the LAMC2 paternal
allele carrying mutation 522-1G®A. The aberrantly spliced transcripts
are represented above and below the mutated allele. Splicing events are
drawn by dotted lines. The mutation and the cryptic splice site within
exon 4 are indicated. (D) RT-PCR ampli®cation followed by AspI
restriction enzyme digestion was carried out using oligonucleotides
spanning the region containing the 858 C/A polymorphism (nt 707±
1145) on cDNA from a normal homozygous C/C individual (lane 1) and
the heterozygous C/A patient (lane 2). Two digested bands of 286 and
153 bp are visible in the C/C homozygous subject. In the patient, the
maternal transcripts correspond to the same 286 and 153 cleaved bands,
whereas the paternal transcripts remain undigested and correspond to the
439 bp band. Note that the intensity of the two maternal bands is similar
to that of the paternal one. The markers for molecular size (100 bp
DNA ladder, from 100 to 2000 bp) are in lane M.
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g2D4 and g2t chains, LSV5 cells were transfected with the
eucaryotic expression vectors pCg2D4 and pCg2t. Expression of
the transfected cDNAs was monitored by immuno¯uorescence
analysis using pAb SE144 speci®c to the laminin g2 chain, and
MoAb GB3 speci®c to the native laminin-5 molecule. In all LSV5
transfected cells, pAb SE144 labeled the keratinocyte cytoplasm and
the matrix deposited by the cells on the plastic culture vessel,
con®rming that both mutant g2 polypeptides are actively
synthesized and secreted (Fig 5). The extracellular staining
appeared less intense in LSV5 cells transfected with either mutant
g2 polypeptide, however, than in those transfected with the control
pCg2 plasmid. Using MoAb GB3, LSV5 cells transfected with
plasmid pCg2D4 showed a labeling of both the cytoplasm and
extracellular matrix (Fig 5). These observations indicate that
mutant g2 polypeptides with an internal deletion in the EGF-like
repeat 3 of domain V assemble into trimeric laminin-5 molecules
that are secreted and incorporated into the matrix. Consistent with
the results obtained with pAb SE144, the staining was less intense in
the g2D4 cells than in cells transfected with the control plasmid. In
contrast, the cells transfected with the pCg2t plasmid were not
reactive to MoAb GB3, which suggests that the mutant g2t chain is
not assembled into trimeric laminin-5 (Fig 5).
DISCUSSION
In this report we describe the molecular defect in a child suffering
from the non-H variant of JEB. Mutation analysis of the LAMC2
gene showed that our proband is a compound heterozygote for two
novel mutations, the de novo splice site mutation 522-1G®A and
the insertion mutation 3511insA, which further extend the
molecular heterogeneity of JEB.
The maternally inherited single base insertion 3511insA leads to a
frameshift spanning 37 amino acids and a downstream PTC in exon
23 of LAMC2 gene, 25 amino acids upstream of the physiologic
termination codon. It is well established that PTC generated by
genetic defects in laminin-5 genes as well as in other genes cause
decay of the aberrant mRNA transcripts leading to undetectable
gene products (Aberdam et al, 1994; Baudoin et al, 1994b; Matsui
et al, 1998; for review see Maquat, 1995). On the other hand, it has
been shown that mRNA decay is less pronounced when a PTC
localizes in the last exon of the mutated gene (Cheng et al, 1990;
Hall and Thein, 1994; for review see Hentze and Kulozik, 1999).
Consistent with this observation, northern blot and allele-speci®c
PCR analysis of the RNA transcripts isolated from our patient
detected signi®cant amounts of mRNA carrying mutation
3511insA that encodes g2 polypeptides (g2t) harboring a
C-terminal stretch of 37 aberrant amino acids and truncated of
the last 25 residues.
The paternal allele mutation 522-1G®A was shown to have
arisen as a de novo event, probably re¯ecting a germ-line mosaicism
in the father, which bears implications for genetic counseling
regarding the risk of recurrence in subsequent offspring. Mutation
522-1G®A affects the acceptor splice site of intron 3, alters the
correct splicing of LAMC2 pre-mRNA, and generates two
mutated transcripts. The major messenger RNA bears an in-
frame deletion of 99 nucleotides (transcript 1) whereas the less
abundant transcript (transcript 2) carries a two-nucleotide deletion
causing a shift of the reading frame. Transcript 2 results from the
activation of a cryptic splice site formed by the ®rst two nucleotides
of exon 4 and carries a PTC at nucleotide 534 that is expected to
cause active mRNA decay. The more abundant transcript 1 carries
the in-frame skipping of exon 4 and codes for a g2 polypeptide
(g2D4) lacking 33 amino acids within the g2 domain V, upstream of
the proteolytic cleavage site of the chain. Exon-skipping leading to
synthesis of internally deleted proteins that maintain a residual
activity has been reported in a number of genes, including those for
laminin-5 (Pulkkinen et al, 1994b, 1998; McGrath et al, 1996,
1999; Posteraro et al, 1998). Speci®cally, a homozygous splice site
mutation leading to the in-frame skipping of LAMC2 exon 9 has
been described in two siblings affected with non-H JEB (Pulkkinen
et al, 1994b).
The genetic studies performed in our patient showed that both
mutations are responsible for the reduced steady-state levels of
LAMC2 mRNA detected by northern analysis. The genetic studies
could not provide information on the contribution of each
mutation to the mild JEB phenotype, however, as both mutant
Figure 5. Immuno¯uorescence staining of g2-null LSV5 cells transiently expressing the wild-type and mutated g2 chains. Forty-eight
hours after transfection, cells were stained with antibodies to laminin g2 chain (a, b, c) and to heterotrimeric laminin-5 (d, e, f). In LSV5 cells the g2
chain and, consequently, laminin-5 molecules are absent (Miquel et al, 1996), but reappear after transfection with the wild-type g2 cDNA resulting in
strong intracytoplasmic and extracellular labeling (a, d). LSV5 cells transfected with plasmid pCg2D4 to express the exon-4-deleted g2 chain show an
intense cytoplasmic labeling and a fainter extracellular staining with both antibodies used (b, e). LSV5 cells transfected with plasmid pCg2t to express the
C-terminal truncated g2 chain show immunostaining with anti-g2 antibody (c) but no reactivity with anti-laminin-5 antibody (f). Transfection
experiments were repeated three times with similar results. Scale bar: 12 mm.
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g2t and g2D4 chains might potentially retain a biologic activity. The
respective effect that the mutant g2t and g2D4 chains have on
laminin-5 synthesis and secretion was therefore assessed in transient
transfection assays of g2-null LSV5 cells using mutant g2 cDNAs.
The ®nding that the mutant g2t chains do not incorporate into
laminin-5 molecules is in keeping with the observation that the
C-terminal regions of the laminin chains are critical for assembly of
the heterotrimers. As for the other laminin isoforms, formation of a
stable b3g2 heterodimer is the initial step in assembly of laminin-5
(Matsui et al, 1995). According to the model proposed by Beck et al
(1993), laminin chain assembly requires formation of a rod-like
triple-stranded a-helical coiled-coil C-terminal domain. In this
structure, the interacting edges of the three chains are mostly
formed by hydrophobic residues in position a and d of an (abcdefg)n
heptad repeat, and by a distinct pattern of charged residues in
positions e and g. In addition, evidence has been provided on the
critical role of short sequences (less than 100 amino acid residues) at
the C-terminal end of each laminin chain for triple-stranded coiled-
coil structure formation (Engel et al, 1991; Hunter et al, 1992;
Nomizu et al, 1994, 1996; Utani et al, 1994; Antonsson et al, 1995;
Kammerer et al, 1995). As shown in Fig 6, the frameshift mutation
3511insA generates several proline and glycine residues that
interrupt the heptad sequence repeat and hamper the a-helicity
and the ionic interactions of the coiled-coil domain I (Garnier et al,
1996). In addition, the truncated g2t chain lacks the 25 C-terminal
residues that include the sequence DVKNLE that is conserved in
the g1 and g2 laminin chains and is required for heterotrimerization
in laminin 1 and laminin 2 (Fig 6A) (Utani et al, 1994). The
cysteine residue (Cys1184) involved in the C-terminal disul®de
interchain bond is also missing (Antonsson et al, 1995).
Conversely, transient transfection assays showed that the mutant
g2D4 chains incorporate into heterotrimeric laminin-5 molecules
Figure 6. Effect of frameshift mutation 3511insA on protein sequence and secondary structure. (A) Alignment and conservation between the
C-terminal sequences of wild-type murine g1 (Swissprot accession No. P02468) and human g2 chains. The mutant g2 chain with the aberrant amino
acid sequence generated by the frameshift mutation 3511insA and starting from residue 1132 is also shown. The `d' positions in the heptad repeat of
laminin long arm is indicated above the sequences. The g1 sequences required for dimer and trimer assembly are boxed. The mutant chain terminates
prematurely at residue 1168. New proline and glycine residues in the mutant sequence that are known to act as a-helix breakers are underlined. (B)
Secondary structure prediction plots according to Garnier et al (1996). The normal sequence shows propensity for a-helix (WT g2). By contrast, the
mutant sequence shows a severe disruption of the a-helix acquiring a random coil pro®le (Mut g2). Black, a-helix; gray, random coil.
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that are secreted and deposited onto the cell culture substrate.
These results suggest that the immunoreactive laminin-5 detected
at the DEJ of our patient corresponds to molecules harboring the
mutated g2D4 chain. We have recently shown that the unprocessed
form of the g2 chain (comprising the short arm domain IV and V)
drives incorporation of laminin-5 into the extracellular matrix
secreted by LSV5-transfected keratinocytes (Gagnoux-Palacios et al,
2001). Mutation analysis based on transfer of mutant g2 cDNAs
into g2-null LSV5 keratinocytes also demonstrated that deletions in
the g2 short arm globular domain IV hamper the deposition of
laminin-5, whereas laminin-5 lacking the epidermal-growth-
factor-like repeat 2 and 3 of the g2 domain V is ef®ciently layered
down (Gagnoux-Palacios et al, 2001). The ®ndings in our non-H
JEB patient are in keeping with these observations and con®rm that
the g2 chain domain V is not essential to the extracellular secretion
and deposition of laminin-5 to the basement membrane.
Amino acid substitutions generated by site-directed mutagenesis
in the g2 domain IV, however, may affect the adhesive function of
laminin-5 without limiting the deposition of the protein, which
underscores the crucial role of the g2 chain short arm in cell
adhesion (Gagnoux-Palacios et al, 2001). Considering that in our
patient the laminin-5 molecules with a mutated g2D4 chain are
correctly processed and layered down, it is tempting to hypothesize
that the deletion of exon 4 within the g2 domain V negatively
affects the adhesive functions of laminin-5 and causes non-H JEB.
Due to both mRNA decay and defective assembly of the g2t chain,
however, the mutated laminin-5 molecules are secreted in reduced
amounts by the patient's keratinocytes. Therefore, the reduced
availability of mutated laminin-5 molecules may destabilize the
basement membrane structure and sensibly enhance the effect of
the mutated g2D4 polypeptide on cell adhesion. Thus, the
pathologic phenotype observed in our non-H JEB patient probably
results from the combined effect of a reduced synthesis and an
altered functionality of laminin-5.
In conclusion, our ®ndings disclose the complex effect that
genetic mutations have in non-H JEB patients that constitute
potential candidates to a gene therapy approach of the condition.
Our results also contribute to a better understanding of the
physiologic functions of the domains of laminin-5.
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